Assura (LON:AGR) Given “Buy” Rating at Peel Hunt

Peel Hunt restated their buy rating on shares of Assura (LON:AGRGet Rating) in a research report released on Tuesday, Marketbeat Ratings reports. Peel Hunt currently has a GBX 65 ($0.81) price objective on the real estate investment trust’s stock.

Separately, Shore Capital reaffirmed a buy rating on shares of Assura in a research note on Tuesday. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from, Assura presently has an average rating of Moderate Buy and an average price target of GBX 61.50 ($0.76).

Assura Stock Down 2.2 %

Assura stock opened at GBX 50.25 ($0.63) on Tuesday. The company’s 50 day simple moving average is GBX 50.30 and its 200 day simple moving average is GBX 53. Assura has a fifty-two week low of GBX 46.88 ($0.58) and a fifty-two week high of GBX 72.35 ($0.90). The firm has a market capitalization of £1.49 billion, a price-to-earnings ratio of 1,256.25, a PEG ratio of 3.60 and a beta of 0.27. The company has a debt-to-equity ratio of 70.19, a current ratio of 2.89 and a quick ratio of 2.84.

Assura Increases Dividend

The firm also recently announced a dividend, which will be paid on Wednesday, July 12th. Investors of record on Thursday, June 8th will be paid a dividend of GBX 0.82 ($0.01) per share. This represents a yield of 1.63%. This is a boost from Assura’s previous dividend of $0.78. The ex-dividend date is Thursday, June 8th. Assura’s dividend payout ratio is presently 7,500.00%.

About Assura

(Get Rating)

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities.

See Also

Analyst Recommendations for Assura (LON:AGR)

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with's FREE daily email newsletter.